As the spread of infectious diseases accelerates, technologies that can accurately distinguish multiple viruses in a single test are becoming increasingly important. KAIST and an international ...
KEYNOTE-859: 4.5-year median follow-up of pembrolizumab plus chemotherapy for previously untreated advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. This is an ASCO ...
Real-world treatment patterns of triple-class refractory (TCR) multiple myeloma (MM) across the United States (US), Canada, and western Europe: A retrospective chart study. Most common treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results